SCNI

Scinai Immunotherapeutics
SCNI

7 hedge funds and large institutions have $58.4K invested in Scinai Immunotherapeutics in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

2.24% less ownership

Funds ownership: 4.81% → 2.57% (-2.2%)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$31.1K
2
+$17.6K
3
+$6.76K
4
UBS Group
UBS Group
Switzerland
+$1.98K

Top Sellers

1
-$18.6K
2
-$1.91K
3
-$213
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$24.6K
XT
2
XTX Topco
Cayman Islands
$19.4K
VF
3
Virtu Financial
New York
$11K
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$1.33K
UBS Group
5
UBS Group
Switzerland
$1.25K
Northwestern Mutual Wealth Management
6
Northwestern Mutual Wealth Management
Wisconsin
$712
Morgan Stanley
7
Morgan Stanley
New York
$41
TSS
8
Two Sigma Securities
New York
–